LLY$1,410.990.46%-6.55
Pre-market: 1,397.12-13.87 -0.98%
Lilly Eli Co (LLY)
Date: 2026-11-02 16:00O: 1,393.15H: 1,421.99L: 1,382.02C: 1,410.99Vol: 3.737M
Lilly Eli Co stock is traded at $1,410.99, with a volume of 3,737,248. It is down -0.46% in the last 24 hours and up +23.46% over the past month. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Previous Close:
$1,417.54
Open:
$1,393.15
24h Volume:
3,737,248
Relative Volume:
1.28
Market Cap:
$1.26T
Revenue:
$72.25B
Net Income/Loss:
$25.28B
P/E Ratio:
50.79
EPS:
$27.78
Net Cash Flow:
$10.37B
1W Performance:
+10.07%
1M Performance:
+23.46%
6M Performance:
+46.47%
1Y Performance:
+57.38%
1-Day Range:
$0.00$0.00
1-Week Range:
$1,260.34$1,449.68
52-Week Range:
$834.19$1,449.68
Lilly Eli Co Stock (LLY) Company Profile
Name
Lilly Eli CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(317) 276-2000Address
LILLY CORPORATE CTR, INDIANAPOLIS, IN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Lilly Eli Co Stock (LLY) Upgrades & Downgrades
Lilly Eli Co Stock (LLY) Financials Data
Lilly Eli Co Stock (LLY) Insider Trading
- LILLY ENDOWMENT, INC.Oct 30 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $1,373.70
- #Shares
- 295,000
- Value ($)
- 405,241,500
- #Shares Total
- 0
- LILLY ENDOWMENT, INC.Oct 15 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $1,208.74
- #Shares
- 305,000
- Value ($)
- 368,665,700
- #Shares Total
- 0
- LILLY ENDOWMENT, INC.Oct 07 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $1,157.49
- #Shares
- 300,000
- Value ($)
- 347,247,000
- #Shares Total
- 0
- Jonsson PatrikAug 17 '26EVP & President, LLY Int'l
- Transaction
- Sale
- Cost
- $1,175.10
- #Shares
- 6,500
- Value ($)
- 7,638,150
- #Shares Total
- 54,147
- Patrik JonssonAug 17 '26Officer
- Transaction
- Proposed Sale
- Cost
- $1,175.10
- #Shares
- 6,500
- Value ($)
- 7,638,150
- #Shares Total
- 0
- DONALD ZAKROWSKIAug 10 '26Officer
- Transaction
- Proposed Sale
- Cost
- $1,185.71
- #Shares
- 2,000
- Value ($)
- 2,371,420
- #Shares Total
- 0
- Zakrowski Donald AAug 10 '26SVP, Finance, & CAO
- Transaction
- Sale
- Cost
- $1,185.01
- #Shares
- 2,000
- Value ($)
- 2,370,020
- #Shares Total
- 1,526
- Hakim AnatAug 07 '26EVP, GC & Secretary
- Transaction
- Sale
- Cost
- $1,190.00
- #Shares
- 5,000
- Value ($)
- 5,950,000
- #Shares Total
- 11,875
- Hakim AnatAug 07 '26Officer
- Transaction
- Proposed Sale
- Cost
- $1,190.00
- #Shares
- 10,000
- Value ($)
- 11,900,000
- #Shares Total
- 0
- Seymour MelissaAug 01 '26EVP, Global Quality
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 981
- Value ($)
- 0
- #Shares Total
- 1,506
